Journal
JOURNAL OF NEUROINTERVENTIONAL SURGERY
Volume 13, Issue 10, Pages 930-934Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/neurintsurg-2020-016906
Keywords
aneurysm; bioactive; coil; device; subarachnoid
Categories
Funding
- Stryker
Ask authors/readers for more resources
The study found that Matrix(2) coils were non-inferior to BMCs after 5 years, but did not show any clear benefit. Post-treatment residual aneurysm filling was strongly associated with target aneurysm recurrence and post-treatment aneurysmal hemorrhage.
Background No randomized trial of intracranial aneurysm coiling has compared long-term efficacy of polymer-modified coils to bare metal coils (BMCs). We report 5-year results comparing Matrix(2) coils to BMCs. The primary objective was to compare the rates of target aneurysm recurrence (TAR) at 12 months. Secondary objectives included angiographic outcomes at TAR or 12 months and TAR at 5 years. Methods A total of 626 patients were randomized to BMCs or Matrix(2) coils. Detailed methods and 1-year results have been published previously. Results Of 580 patients eligible for 5-year follow-up, 431 (74.3%) completed follow-up or reached TAR. Matrix(2) coils were non-inferior to BMCs (P=0.8) but did not confer any benefit. Core lab reported post-treatment residual aneurysm filling (Raymond III) correlated with TAR (P<0.0001) and with aneurysm hemorrhage after treatment (P<0.008). Repeat aneurysmal hemorrhage after treatment, but before hospital discharge, occurred in three patients treated for acutely ruptured aneurysms. Additionally, two patients treated for unruptured aneurysms experienced a first hemorrhage during follow-up. All five hemorrhages resulted from aneurysms with Raymond III residual aneurysm filling persisting after initial treatment. After 5 years follow-up, 2/626 (0.3%) patients are known to have had target aneurysm rupture following hospital discharge. The annualized rate of delayed hemorrhage after coiling was 2/398/5=0.001 (0.1%) per year for unruptured aneurysms and 0 for ruptured aneurysms. Conclusions After 5 years Matrix(2) coils were non-inferior to BMCs but no benefit was demonstrated. Post-treatment residual angiographic aneurysm filling (Raymond III) is strongly associated with TAR (P<0.0001) and post-treatment aneurysmal hemorrhage (P=0.008).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available